@pliantrx.com
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-Ξ² pathway.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Pliant Therapeutics is a brand at the forefront of drug development programs targeting fibrotic diseases. With a strong focus on inhibiting integrins and the TGF-Ξ² pathway in fibrotic tissue, Pliant is committed to bringing hope to patients with fibrosis through the discovery and development of breakthrough therapies. Pliant's approach revolves around understanding the molecular drivers of fibrotic diseases to unlock potentially safer and more effective treatments for patients.
Led by a highly experienced team of fibrosis and drug development experts, Pliant's broad pipeline includes two clinical stage programs, including the first clinical stage, oral, selective small molecule integrin inhibitor. Pliant recognizes the crucial role patients play in advancing the treatment of fibrosis and emphasizes the importance of patient participation. They strive to create a collaborative environment where patients' voices are heard and incorporated into their research and development process.
Stay updated with the latest news and developments from Pliant Therapeutics, and explore career opportunities with a company that is passionate about delivering breakthrough therapies to patients
Company Type
Public Company
Company Size
51-200
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories